title: Curdlan sulfate induces the downmodulation of chemokine receptors leading to suppression of HIV infection.
authors.forename: T
authors.initials: T
authors.lastname: Naito
authors.forename: M
authors.initials: M
authors.lastname: Okada
authors.forename: H
authors.initials: H
authors.lastname: Ogasawara
authors.forename: H
authors.initials: H
authors.lastname: Kaneko
authors.forename: T
authors.initials: T
authors.lastname: Hishikawa
authors.forename: T
authors.initials: T
authors.lastname: Matsumoto
authors.forename: I
authors.initials: I
authors.lastname: Sekigawa
authors.forename: H
authors.initials: H
authors.lastname: Hashimoto
authors.forename: Y
authors.initials: Y
authors.lastname: Kaneko
mesh_terms: D019380:Anti-HIV Agents / Q000494:pharmacology*; D015536:Down-Regulation; D005936:Glucans / Q000494:pharmacology*; D015658:HIV Infections / Q000188:drug therapy / Q000821:virology*; D015497:HIV-1 / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D007963:Leukocytes, Mononuclear / Q000187:drug effects* / Q000378:metabolism / Q000821:virology; D019713:Receptors, CCR5 / Q000187:drug effects / Q000378:metabolism*; D047071:beta-Glucans
chemical_list: D019380:Anti-HIV Agents; D005936:Glucans; D019713:Receptors, CCR5; D047071:beta-Glucans; C063130:curdlan sulfate